Literature DB >> 15665352

Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree.

C Toomes1, L M Downey, H M Bottomley, H A Mintz-Hittner, C F Inglehearn.   

Abstract

BACKGROUND/AIMS: Familial exudative vitreoretinopathy (FEVR) is an inherited blinding condition characterised by abnormal development of the retinal vasculature. The aim of this study was to perform linkage analysis in a large family affected with FEVR to determine whether the mutation involved was in one of the three known autosomal dominant FEVR loci or in another as yet unidentified gene.
METHODS: Genomic DNA samples from family members were polymerase chain reaction (PCR) amplified with fluorescently tagged microsatellite markers spanning the EVR1/EVR4 locus (11q13-14) and the EVR3 locus (11p12-13). The resulting PCR products were resolved using an automated DNA sequencer and the alleles sized. These data were used to construct haplotypes across each locus and linkage analysis was performed to prove or exclude linkage.
RESULTS: The clinical evaluation in this family suggested features typical of FEVR, with deficient peripheral retinal vascularisation being the common phenotype in all affected individuals. However, linkage analysis proved that this family has a form of FEVR genetically distinct from the EVR1, EVR3 and EVR4 loci.
CONCLUSION: The exclusion of linkage in this family to any of the known FEVR loci proves the existence of a fourth locus for autosomal dominant FEVR and shows that this rare disorder is far more heterogeneous than previously thought.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665352      PMCID: PMC1772516          DOI: 10.1136/bjo.2004.042507

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  31 in total

1.  Familial exudative vitreoretinopathy linked to D11S533 in a large Asian family with consanguinity.

Authors:  S M Price; N Periam; A Humphries; G Woodruff; R C Trembath
Journal:  Ophthalmic Genet       Date:  1996-06       Impact factor: 1.803

2.  Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity.

Authors:  B S Shastry; M T Trese
Journal:  Am J Med Genet       Date:  1997-03-17

3.  Evidence for genetic heterogeneity in X-linked familial exudative vitreoretinopathy.

Authors:  B S Shastry; X Liu; J F Hejtmancik; D A Plager; M T Trese
Journal:  Genomics       Date:  1997-09-01       Impact factor: 5.736

4.  Familial exudative vitreoretinopathy. An expanded view.

Authors:  J Gow; G L Oliver
Journal:  Arch Ophthalmol       Date:  1971-08

5.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

6.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

7.  X-linked exudative vitreoretinopathy caused by an arginine to leucine substitution (R121L) in the Norrie disease protein.

Authors:  K Johnson; H A Mintz-Hittner; Y P Conley; R E Ferrell
Journal:  Clin Genet       Date:  1996-09       Impact factor: 4.438

8.  Comprehensive human genetic maps: individual and sex-specific variation in recombination.

Authors:  K W Broman; J C Murray; V C Sheffield; R L White; J L Weber
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

Review 9.  Molecular dissection of Norrie disease.

Authors:  W Berger
Journal:  Acta Anat (Basel)       Date:  1998

10.  Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity.

Authors:  G de Crecchio; F Simonelli; G Nunziata; S Mazzeo; G M Greco; E Rinaldi; V Ventruto; A Ciccodicola; M G Miano; F Testa; A Curci; M D'Urso; M M Rinaldi; M L Cavaliere; P Castelluccio
Journal:  Clin Genet       Date:  1998-10       Impact factor: 4.438

View more
  7 in total

1.  Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5.

Authors:  L M Downey; H M Bottomley; E Sheridan; M Ahmed; D F Gilmour; C F Inglehearn; A Reddy; A Agrawal; J Bradbury; C Toomes
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

Review 2.  Wnt signaling in angiogenesis.

Authors:  Nancy L Parmalee; Jan Kitajewski
Journal:  Curr Drug Targets       Date:  2008-07       Impact factor: 3.465

3.  WNT Stimulation Dissociates a Frizzled 4 Inactive-State Complex with Gα12/13.

Authors:  Elisa Arthofer; Belma Hot; Julian Petersen; Katerina Strakova; Stefan Jäger; Manuel Grundmann; Evi Kostenis; J Silvio Gutkind; Gunnar Schulte
Journal:  Mol Pharmacol       Date:  2016-07-25       Impact factor: 4.436

4.  Blindness from bilateral bullous retinal detachment: tragedy of a Nigerian family.

Authors:  Bernice O Adegbehingbe
Journal:  Afr Health Sci       Date:  2008-03       Impact factor: 0.927

5.  Developmental vascular regression is regulated by a Wnt/β-catenin, MYC and CDKN1A pathway that controls cell proliferation and cell death.

Authors:  Gowri Nayak; Yoshinobu Odaka; Vikram Prasad; Alyssa F Solano; Eun-Jin Yeo; Shruti Vemaraju; Jeffery D Molkentin; Andreas Trumpp; Bart Williams; Sujata Rao; Richard A Lang
Journal:  Development       Date:  2018-06-14       Impact factor: 6.868

6.  Pediatric cataract, myopic astigmatism, familial exudative vitreoretinopathy and primary open-angle glaucoma co-segregating in a family.

Authors:  D A Mackey; A W Hewitt; J B Ruddle; B Vote; R G Buttery; C Toomes; R Metlapally; Y J Li; K N Tran-Viet; F Malecaze; P Calvas; T Rosenberg; J A Guggenheim; T L Young
Journal:  Mol Vis       Date:  2011-08-10       Impact factor: 2.367

7.  A new recessively inherited disorder composed of foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis maps to chromosome 16q23.3-24.1.

Authors:  Musallam Al-Araimi; Bishwanath Pal; James A Poulter; Maria M van Genderen; Ian Carr; Tomas Cudrnak; Lawrence Brown; Eamonn Sheridan; Moin D Mohamed; John Bradbury; Manir Ali; Chris F Inglehearn; Carmel Toomes
Journal:  Mol Vis       Date:  2013-11-01       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.